Aristada (aripiprazole lauroxil) is a prescription drug that’s used to treat schizophrenia. Aristada is given by a healthcare professional as an injection into a muscle. Aristada is used as a ...

Credit: Thinkstock. Abilify Asimtufii is intended for dosing every 2 months via intramuscular injection in the gluteal muscle. The Food and Drug Administration (FDA) has approved Abilify Asimtufii ® ...

Aripiprazole is a generic prescription medication that’s prescribed for certain mental health conditions. Aripiprazole belongs to a class of drugs a called atypical antipsychotics. A class of drugs is ...

Aripiprazole, often sold under the brand name 'Abilify', is a type of medication which is typically used to treat psychotic symptoms, such as hallucinations, delusions and confused, disturbed thoughts ...

The first image in Otsuka and Lundbeck’s new Abilify Maintena TV commercial is a close-up shot of a bipolar I patient’s hands. Her wedding ring and French-manicured nails are front and center as she ...

This is an excerpt from a story delivered exclusively to Business Insider Intelligence Digital Health Pro subscribers. To receive the full story plus other insights each morning, click here. The FDA ...

In late 2017, the Food and Drug Administration approved the first so-called smart pill, ushering in a new era of medical care. The inaugural effort involved embedding a sensor in Abilify, an old drug ...

Japanese pharmaceutical company Otsuka’s best known effort in mental health has probably been the development of anti-psychotic drug Abilify, which was brought to the U.S. market through a partnership ...

Cheap abilify canada express shipping PThese drugs are used together with β-blockers and diuretics if used in resistant hypertension. The site of drug is in the north, probably the medulla, and the ...

Abilify or generic Aripiprazole is an atypical antipsychotic and antidepressant drug which alters thinking and behavior by targeting certain chemicals in the brain. Abilify is prescribed to treat a ...

(Reuters) - Otsuka Pharmaceutical Co Ltd has lost a lawsuit challenging the U.S. Food and Drug Administration's decision to allow generic versions of the company's antipsychotic drug Abilify. At the ...

PRINCETON, NJ and TOKYO, JAPAN, November 20, 2007 – Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) ...